Tailored care for patients with possible pneumonia who test positive for viruses

✅ Just Accepted
🔗 https://bit.ly/4cyU7Er

The population-level impact of doxycycline post-exposure prophylaxis on syphilis in King County, WA: an interrupted time series analysis

✅ Just Accepted
🔗 https://bit.ly/3Qv64U1

Doxycycline prophylaxis for syphilis: proceed with caution

✅ Just Accepted
#IDTwitter

🔗 https://bit.ly/4cwBHEi

Targeted peri-operative prophylaxis in patients colonized with Carbapenem Resistant Enterobacterales undergoing Liver Transplantation: a multinational cohort study

✅ Just Accepted
🔗 https://bit.ly/4vDAVOe

Invisible Malarias

✅ Just Accepted
#IDTwitter

🔗 https://bit.ly/4vHmARa

Frequent Plasmodium ovale recurrence in coastal Tanzania

✅ Just Accepted
#IDTwitter

🔗 https://bit.ly/4mCwLlS

Street Stewardship: The next frontier to address antibiotic resistance and health inequities

✅ Just Accepted
🔗 https://bit.ly/48QEpTM

Concerns Regarding Study Prioritization and Statistical Power in Evaluating Oral Versus Intravenous Therapy

✅ Just Accepted
🔗 https://bit.ly/4853k5Z

Vectors are not just culture vessels

✅ Just Accepted
#IDTwitter

🔗 https://bit.ly/4sAOFXk

Recombinant vs Standard Influenza Vaccine in Adults With Severe Obesity: A Randomized Clinical Trial

✅ Just Accepted
🔗 https://bit.ly/4uaKeUH

The Stercorarian Amplification Advantage: Transmission Biology Determines Xenodiagnostic Sensitivity

✅ Just Accepted
🔗 https://bit.ly/4cyiodQ

Comparison of ceftolozane-tazobactam and ceftazidime-avibactam in the treatment of MDR/DTR Pseudomonas aeruginosa infections: a systematic review and meta-analysis

✅ Just Accepted
🔗 https://bit.ly/4tfsk2S

When Switching Antiretroviral Therapy Is Not Enough

✅ Just Accepted
#IDTwitter

🔗 https://bit.ly/4tllSHq

The latest CID supplement issue examines key aspects of tuberculosis (TB), including transmission, disease progression, diagnostic approaches, and treatment strategies.

↪️ https://bit.ly/3On4jaL

Limited durability of improvements in infection prevention and control practices following reactive interventions leaves healthcare facilities vulnerable to Ebola virus transmission

✅ Just Accepted
🔗 https://bit.ly/4tcBOMg

A 48-week, Randomized Controlled Trial of Doravirine for Individuals with HIV and Obesity on Integrase Inhibitors and Tenofovir Alafenamide: The Do IT Study (ACTG A5391)

✅ Just Accepted
🔗 https://bit.ly/4tJXfEh

2026 Clinical Practice Guideline Update by IDSA and PIDS on The Management of Community-acquired Pneumonia in Infants and Children Older than 3 Months of Age: The Choice of Chest Tube Size

✅ Just Accepted
🔗 https://bit.ly/4ehciRe

2026 Clinical Practice Guideline Update by IDSA and PIDS on The Management of Community-acquired Pneumonia in Infants and Children Older than 3 Months of Age: The Use of tPa and DNase or tPa Alone for Fibrinolysis

✅ Just Accepted
🔗 https://bit.ly/4cDFtgb

Long-Term Serologic Outcomes Following Treatment of Syphilis in People With HIV: A Prospective Cohort Study In a homogeneous cohort of 184 people with HIV and first-episode syphilis, treatment response occurred at 6 months and was linked to baseline RPR and nadir

Long-Term Serologic Outcomes Following Treatment of Syphilis in People With HIV: A Prospective Cohort Study

✅ Just Accepted
🔗 https://bit.ly/4vmBR9J

2026 Clinical Practice Guideline Update by IDSA and PIDS on The Management of Community-Acquired Pneumonia in Infants and Children Older than 3 Months of Age: The Use of Pleural fluid drainage compared to Surgical Debridement

✅ Just Accepted
🔗 https://bit.ly/3PKO341

Clinical Practice Guideline by IDSA and PIDS: 2026 Guideline Update on The Management of Community-Acquired Pneumonia in Infants and Children Older than 3 Months of Age

✅ Just Accepted
🔗 https://bit.ly/4vgm38t

2026 Clinical Practice Guideline Update by IDSA and PIDS on The Management of Community-Acquired Pneumonia in Infants and Children Older than 3 Months of Age: The Use of Chest Ultrasound in Children with Parapneumonic Effusion

✅ Just Accepted
🔗 https://bit.ly/4sZyp3k

Evaluation of the impact of universal mupirocin decolonization in intensive care units on the utility of MRSA PCR nasal swab testing

✅ Just Accepted
🔗 https://bit.ly/4bWBN9b

Nasal decolonization and PCR screening in the ICU: friend or foe?

✅ Just Accepted
🔗 https://bit.ly/4sU5iOF

Antiretroviral Activity, Pharmacokinetics, and Safety of MK-8527, an Oral Nucleoside Reverse Transcriptase Translocation Inhibitor, in Adults Living With HIV-1 Who Had Not Previously Taken Antiretroviral Agents

✅ Just Accepted
🔗 https://bit.ly/3NQNAwy

Safety and Tolerability of Oral Islatravir Once Monthly as Pre-Exposure Prophylaxis in Cisgender Men and Transgender Women Who Have an Elevated Likelihood of HIV-1 Exposure: Results From the IMPOWER-24 Randomized Phase 3 Study

✅ Just Accepted
🔗 https://bit.ly/4vkJ22q

Cephalosporins Versus Non-cephalosporin Antibiotics for Perioperative Prophylaxis in Primary Arthroplasty: A Systematic Review and Meta-Analysis

✅ Just Accepted
🔗 https://bit.ly/3Qn2Xxm

Estimating Changes in Facility MRSA Infection Rates Due to Changes in MRSA Precaution Policy This study leveraged COVID-19–related changes in MRSA prevention across 121 VA hospitals to assess effects of contact precautions and surveillance. Effects

Estimating Changes in Facility MRSA Infection Rates Due to Changes in MRSA Precaution Policy

✅ Just Accepted
🔗 https://bit.ly/4bNC78E

When are uncontrolled trials in TB scientifically and ethically justified: Borrowing wisdom from early AIDS clinical trials

✅ Just Accepted
🔗 https://bit.ly/4bPWGTk

A Turning Point for Hepatitis C Care: Point-of-Care HCV RNA Authorization as a Critical First Step Towards Integrated Test-and-Treat Models in the United States

✅ Just Accepted
🔗 https://bit.ly/4sRnp87